Central nervous system involvement and relapse in adult acute lymphoblastic leukaemia—a population‐based analysis in 2007–2022

Documenti analoghi

• Hypomethylating agent and venetoclax are effective salvage therapies in relapsed/refractory early T‐cell precursor acute lymphoblastic leukaemia
  di: Vaibhav Agrawal, et al.
  Pubblicazione: (2025)
• Successful combined anti‐CD19 immunotherapy of relapsed acute lymphoblastic leukaemia in a child with Nijmegen breakage syndrome
  di: A. Oszer, et al.
  Pubblicazione: (2025)
• Clinical features and incidence of central nervous system involvement in patients with adult T‐cell leukaemia/lymphoma
  di: Takuya Ueno, et al.
  Pubblicazione: (2026)
• The efficacy of targeted and immune‐based therapies in adults with TP53‐mutated acute lymphoblastic leukaemia
  di: Hoda Pourhassan, et al.
  Pubblicazione: (2025)
• Better late than never: Delayed asparaginase during induction for acute lymphoblastic leukaemia in adults
  di: Yannis K. Valtis, et al.
  Pubblicazione: (2024)